Christoffer Soendergaard1,2, Peter Helding Kvist3, Jakob Benedict Seidelin4, Hermann Pelzer5, Ole Haagen Nielsen4. 1. Department of Gastroenterology 54O3, Medical Section, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, 2730, Herlev, Denmark. christoffer.soendergaard@regionh.dk. 2. Department of Histology and Bioimaging, Novo Nordisk A/S, Maaloev, Denmark. christoffer.soendergaard@regionh.dk. 3. Department of Histology and Bioimaging, Novo Nordisk A/S, Maaloev, Denmark. 4. Department of Gastroenterology 54O3, Medical Section, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, 2730, Herlev, Denmark. 5. Department of Research Bioanalysis, Novo Nordisk A/S, Maaloev, Denmark.
Abstract
BACKGROUND: Subunit A of coagulation factor XIII (FXIII-A) is important for clot stability and acts in the subsequent wound healing process. Loss of plasma FXIII-A has been reported after surgery, sepsis, and inflammatory conditions. In the intestinal mucosa, FXIII-A is expressed by macrophages and cellular FXIII-A has been associated with phagocytosis and migration of macrophages. The objective was to evaluate the consequences of intestinal inflammation on resident mucosal macrophages, focusing on the level and distribution of FXIII-A. METHODS: Plasma and colonic biopsies were collected from 67 patients with ulcerative colitis and controls. Intestinal samples were stained using immunohistochemistry for FXIII-A and macrophages (CD68, CD163 and iNOS). In situ hybridization were used to assess the intestinal expression of FXIII-A. FXIII-A antigen and activity levels were measured in plasma. RESULTS: Increased infiltration of CD68 positive macrophages in the inflamed mucosa coincided with increased extracellular deposited FXIII-A and decreased expression and intracellular protein levels of FXIII-A. A decreased proportion of FXIII-A/CD68/CD163 triple-positive macrophages was observed in inflamed mucosa, indicating a reduction of the M2 phenotype with consequent loss of FXIII-A. No induction of iNOS positive macrophages was observed. Stimulation of naïve monocytes with physiological concentrations of pro-inflammatory mediators negatively affected the expression of FXIII-A. Measurements in plasma confirmed the loss of both FXIII antigen and activity during active disease. CONCLUSIONS: Intestinal inflammation in UC induces loss of M2 macrophages with subsequent loss of FXIII-A synthesis. The loss of cellular FXIII-A may impact migration and phagocytosis, and hence limit pathogen eradication in UC.
BACKGROUND: Subunit A of coagulation factor XIII (FXIII-A) is important for clot stability and acts in the subsequent wound healing process. Loss of plasma FXIII-A has been reported after surgery, sepsis, and inflammatory conditions. In the intestinal mucosa, FXIII-A is expressed by macrophages and cellular FXIII-A has been associated with phagocytosis and migration of macrophages. The objective was to evaluate the consequences of intestinal inflammation on resident mucosal macrophages, focusing on the level and distribution of FXIII-A. METHODS: Plasma and colonic biopsies were collected from 67 patients with ulcerative colitis and controls. Intestinal samples were stained using immunohistochemistry for FXIII-A and macrophages (CD68, CD163 and iNOS). In situ hybridization were used to assess the intestinal expression of FXIII-A. FXIII-A antigen and activity levels were measured in plasma. RESULTS: Increased infiltration of CD68 positive macrophages in the inflamed mucosa coincided with increased extracellular deposited FXIII-A and decreased expression and intracellular protein levels of FXIII-A. A decreased proportion of FXIII-A/CD68/CD163 triple-positive macrophages was observed in inflamed mucosa, indicating a reduction of the M2 phenotype with consequent loss of FXIII-A. No induction of iNOS positive macrophages was observed. Stimulation of naïve monocytes with physiological concentrations of pro-inflammatory mediators negatively affected the expression of FXIII-A. Measurements in plasma confirmed the loss of both FXIII antigen and activity during active disease. CONCLUSIONS:Intestinal inflammation in UC induces loss of M2 macrophages with subsequent loss of FXIII-A synthesis. The loss of cellular FXIII-A may impact migration and phagocytosis, and hence limit pathogen eradication in UC.
Authors: Mumtaz Hayat; Robert A S Ariëns; Paul Moayyedi; Peter J Grant; Seamus O'Mahony Journal: Eur J Gastroenterol Hepatol Date: 2002-03 Impact factor: 2.566
Authors: Zhi Wang; Christine Wilhelmsson; Pavel Hyrsl; Torsten G Loof; Pavel Dobes; Martina Klupp; Olga Loseva; Matthias Mörgelin; Jennifer Iklé; Richard M Cripps; Heiko Herwald; Ulrich Theopold Journal: PLoS Pathog Date: 2010-02-12 Impact factor: 6.823
Authors: Sergey B Zaets; Da-Zhong Xu; Qi Lu; Eleonora Feketova; Tamara L Berezina; Maryann Gruda; Inga V Malinina; Edwin A Deitch; Eva H N Olsen Journal: Shock Date: 2009-06 Impact factor: 3.454
Authors: Attila Sárváry; Sándor Szucs; Imre Balogh; Aron Becsky; Helga Bárdos; Mária Kávai; Uri Seligsohn; Rudolf Egbring; Stanislaw Lopaciuk; László Muszbek; Róza Adány Journal: Cell Immunol Date: 2004-04 Impact factor: 4.868
Authors: Susan L Stevens; Tao Liu; Frances Rena Bahjat; Vladislav A Petyuk; Athena A Schepmoes; Ryan L Sontag; Marina A Gritsenko; Chaochao Wu; Sheng Wang; Anil K Shukla; Jon M Jacobs; Richard D Smith; Karin D Rodland; G Alexander West; Steven G Kohama; Christine Glynn; Mary P Stenzel-Poore Journal: Transl Stroke Res Date: 2018-10-19 Impact factor: 6.829
Authors: Christoffer Soendergaard; Peter Helding Kvist; Peter Thygesen; Mats Reslow; Ole Haagen Nielsen; John Joseph Kopchick; Thomas Lindebo Holm Journal: Int J Mol Sci Date: 2017-09-23 Impact factor: 5.923
Authors: Mari T Kaartinen; Mansi Arora; Sini Heinonen; Aila Rissanen; Jaakko Kaprio; Kirsi H Pietiläinen Journal: Int J Mol Sci Date: 2020-11-05 Impact factor: 5.923